A certain amount of blood pressure medication was recalled after a bottle of this lot was labeled as incorrect, according to a statement by the Food and Drug Administration (FDA).

The bottle should contain hydrochlorothiazide tablets USP 12.5 mg, a drug used to treat high blood pressure, instead contained USP 25 mg spironolactone tablets – used to treat congestive heart failure, cirrhosis, and other diseases.

The FDA says that the effects of mixing the drugs on the

Accord Healthcare Inc. voluntarily recalled a single batch of the drug PW05264 after research revealed that it was the only potentially affected batch.

Accord & # 39 ; s hydrochlorothiazide tablets USP 12.5 mg can be identified by a visual Leader . The tablets should be bright orange or peach-colored and round. They have an "H" and a "1" on opposite sides.

For individuals holding Accord Hydrochlorothiazide tablets that do not conform to this description, the FDA recommends that you check with a pharmacy or health care provider.

Accord says there have been no reports of adverse events related to this recall under FDA clearance.

Autoplay

Show thumbnails

Show captions

Last slideNext item

Read or Share This story: https://usat.ly/2wmTieD